PointState Capital’s UnitedHealth UNH Stock Holding History

PointState Capital’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,000	Closed	-$5.86M	–	174
2021 Q3	$5.86M	Buy	+15,000	New	+$6.21M	0.1%	99

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PointState Capital's UNH Position: Q3 2023 in Review

PointState Capital sold out of UnitedHealth (UNH) in Q3 2023, closing a stake of 1,559 shares — an estimated $749K sold.

PointState Capital first reported a position in UNH in Q4 2018 and held it in 12 quarters. The position peaked at $135M in Q3 2020. 3,138 funds tracked by Wall St. Rank hold UNH as of Q3 2023.

PointState Capital reported no remaining UnitedHealth position as of Q3 2023 after selling out during the quarter.
PointState Capital sold 1,559 UnitedHealth shares in Q3 2023, an estimated $749K.
PointState Capital first reported a position in UnitedHealth in Q4 2018 and held it in 12 quarters.
PointState Capital's UnitedHealth position peaked at $135M in Q3 2020.
3,138 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2023.

Based on PointState Capital's 13F filing for Q3 2023, filed 14 Nov 2023.